GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Avricore Health Inc (OTCPK:AVCRF) » Definitions » Net Cash per Share

Avricore Health (Avricore Health) Net Cash per Share : $0.00 (As of Dec. 2023)


View and export this data going back to 2009. Start your Free Trial

What is Avricore Health Net Cash per Share?

Net Cash per Share is calculated as Cash, Cash Equivalents, Marketable Securities minus Total Liabilities minus Minority Interest and then divided by Shares Outstanding (EOP). Avricore Health's Net Cash per Share for the quarter that ended in Dec. 2023 was $0.00.

The historical rank and industry rank for Avricore Health's Net Cash per Share or its related term are showing as below:

During the past 13 years, the highest Price-to-Net-Cash Ratio of Avricore Health was 32.00. The lowest was 8.00. And the median was 18.89.

AVCRF's Price-to-Net-Cash is not ranked *
in the Medical Diagnostics & Research industry.
Industry Median: 6.995
* Ranked among companies with meaningful Price-to-Net-Cash only.

Avricore Health Net Cash per Share Historical Data

The historical data trend for Avricore Health's Net Cash per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Avricore Health Net Cash per Share Chart

Avricore Health Annual Data
Trend Jun14 Jun15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Net Cash per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.01 -0.01 0.02 - -

Avricore Health Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Jun23 Sep23 Dec23
Net Cash per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Avricore Health's Net Cash per Share

For the Diagnostics & Research subindustry, Avricore Health's Price-to-Net-Cash, along with its competitors' market caps and Price-to-Net-Cash data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Avricore Health's Price-to-Net-Cash Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Avricore Health's Price-to-Net-Cash distribution charts can be found below:

* The bar in red indicates where Avricore Health's Price-to-Net-Cash falls into.



Avricore Health Net Cash per Share Calculation

In the calculation of a company's Net Cash per Share, assets other than cash and short term investments are considered to be worth nothing. But the company has to pay its debt and other liabilities in full. This is an extremely conservative way of valuation. Most companies have negative Net Cash per Share. But sometimes a company's price may be lower than its net-cash.

Avricore Health's Net Cash per Share for the fiscal year that ended in Dec. 2023 is calculated as

Net Cash per Share (A: Dec. 2023 )
=(Cash, Cash Equivalents, Marketable Securities-Total Liabilities-Minority Interest)/Shares Outstanding (EOP)
=(0.214-0.394-0)/99.6447
=-0.00

Avricore Health's Net Cash per Share for the quarter that ended in Dec. 2023 is calculated as

Net Cash per Share (Q: Dec. 2023 )
=(Cash, Cash Equivalents, Marketable Securities-Total Liabilities-Minority Interest)/Shares Outstanding (EOP)
=(0.214-0.394-0)/99.6447
=-0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Avricore Health  (OTCPK:AVCRF) Net Cash per Share Explanation

Ben Graham invested in situations where the company's stock price was lower than its net-cash. He assigned some value to the company's other current asset. The value is called Net Current Asset Value (NCAV). One research study, covering the years 1970 through 1983 showed that portfolios picked at the beginning of each year, and held for one year, returned 29.4 percent, on average, over the 13-year period, compared to 11.5 percent for the S&P 500 Index. Other studies of Graham's strategy produced similar results.

You can find companies that are traded below their Net Current Asset Value (NCAV) with our Net-Net screener.


Avricore Health Net Cash per Share Related Terms

Thank you for viewing the detailed overview of Avricore Health's Net Cash per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Avricore Health (Avricore Health) Business Description

Traded in Other Exchanges
Address
1120 - 789 West Pender Street, Vancouver, BC, CAN, V6C 1H2
Avricore Health Inc is a Canada based company. The company is involved in the business of health data and point-of-care technologies. The Company has only one segment, being the HealthTab - Point of Care Business in Canada. The Company's revenues are generated from operating leases of the POCT system and sale of testing panels.

Avricore Health (Avricore Health) Headlines

From GuruFocus

VANC Pharmaceuticals Inc. Provides Corporate Update

By GlobeNewswire GlobeNewswire 11-02-2018

Avricore Health Amends Options

By GlobeNewswire GlobeNewswire 09-11-2020

Avricore Health Announces Lifting of Management Cease Trade Order

By Marketwired Marketwired 06-04-2019

Emerald Health Therapeutics Expands Strategic Investment in VANC

By Marketwired Marketwired 04-17-2018

Avricore Health Extends Closing of Placement

By GlobeNewswire GlobeNewswire 07-20-2019

VANC Announces Agreement for Acquisition of Corozon Platform

By GlobeNewswire GlobeNewswire 04-12-2018